ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance Portfolio News / By admin August 8, 2019 ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance Read More »
Ribon Therapeutics Strengthens Management Team with Appointment of Sudha Parasuraman, M.D., as Chief Medical Officer and Edward Stewart as Chief Business Officer Portfolio News / By admin August 6, 2019 Ribon Therapeutics Strengthens Management Team with Appointment of Sudha Parasuraman, M.D., as Chief Medical Officer and Edward Stewart as Chief Business Officer Read More »
Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development Portfolio News / By admin July 17, 2019 Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development Read More »
REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers Portfolio News / By admin July 9, 2019 REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers Read More »
ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer Portfolio News / By admin July 9, 2019 ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer Read More »
Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer Portfolio News / By admin June 24, 2019 Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer Read More »
RAPT Therapeutics (Formerly FLX Bio) Completes $37 Million Series C Extension Portfolio News / By admin June 18, 2019 RAPT Therapeutics (Formerly FLX Bio) Completes $37 Million Series C Extension Read More »
Exonics Therapeutics Acquired by Vertex, Expanding into New Disease Areas and Enhances Gene Editing Capabilities Portfolio News / By admin June 6, 2019 Exonics Therapeutics Acquired by Vertex, Expanding into New Disease Areas and Enhances Gene Editing Capabilities Read More »
Constellation’s Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients Portfolio News / By admin June 3, 2019 Constellation’s Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients Read More »
FLX Bio Announces Name Change to RAPT Therapeutics Portfolio News / By admin May 24, 2019 FLX Bio Announces Name Change to RAPT Therapeutics Read More »
